(Q38730936)

English

Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer

scientific article published on 12 April 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 September 2017

Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer (English)

1 reference

Europe PubMed Central

5 September 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

tumor-infiltrating immune cell

1 reference

based on heuristic

inferred from title

author name string

Kyu Sang Lee

1

1 reference

Europe PubMed Central

5 September 2017

Yoonjin Kwak

2

1 reference

Europe PubMed Central

5 September 2017

Soyeon Ahn

3

1 reference

Europe PubMed Central

5 September 2017

Eun Shin

4

1 reference

Europe PubMed Central

5 September 2017

Heung-Kwon Oh

5

1 reference

Europe PubMed Central

5 September 2017

Duck-Woo Kim

6

1 reference

Europe PubMed Central

5 September 2017

Sung-Bum Kang

7

1 reference

Europe PubMed Central

5 September 2017

Gheeyoung Choe

8

1 reference

Europe PubMed Central

5 September 2017

Woo Ho Kim

9

1 reference

Europe PubMed Central

5 September 2017

Hye Seung Lee

10

1 reference

Europe PubMed Central

5 September 2017

publication date

12 April 2017

1 reference

Europe PubMed Central

5 September 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

5 September 2017

66

1 reference

Europe PubMed Central

5 September 2017

7

1 reference

Europe PubMed Central

5 September 2017

927-939

1 reference

Europe PubMed Central

5 September 2017

https://scigraph.springernature.com/pub.10.1007/s00262-017-1999-6

0 references

Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

PD-L1 and Survival in Solid Tumors: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Significance of Programmed Death Ligand 1 (PD-L1) Immunohistochemical Expression in Colorectal Cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Histopathological identification of colon cancer with microsatellite instability

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Protein expression profiling and molecular classification of gastric cancer by the tissue array method.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

How to read a paper. Statistics for the non-statistician. I: Different types of data need different statistical tests

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Characterization of an adaptive immune response in microsatellite-instable colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Cancer immunoediting from immune surveillance to immune escape

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Immune cells: plastic players along colorectal cancer progression

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Molecular phenotypes of colorectal cancer and potential clinical applications

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Identifiers

10.1007/S00262-017-1999-6

1 reference

Europe PubMed Central

5 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

5 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38730936&oldid=1781315502"